In a translation case-control study, exenatide significantly upregulated co-expressions of PSMA2 protein, and GLP-1 receptor in cervical cancer specimens gained from patients with diabetes were reduced by exenatide [46]. This evidence concerns the gene GLP1R and diabetes mellitus.